A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma.

The aim of the protocol was to evaluate the side-effects induced by repeated tumour-infiltrating lymphocyte (TIL) infusions in patients with metastatic melanoma (MM). Patients were to receive four TIL infusions at given intervals: every 3 weeks (two patients), every 2 weeks (3 patients) and weekly (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravaud, A., Legrand, E., Delaunay, M. M., Bussières, E., Coulon, V., Cany, L., Huet, S., Verdier, D., Kind, M., Chomy, F.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033579/
https://www.ncbi.nlm.nih.gov/pubmed/7530984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033579/
https://www.ncbi.nlm.nih.gov/pubmed/7530984

Ejemplares similares